StockNews.AI
STAA
StockNews.AI
23 days

Broadwood Announces Intent to Vote Against Acquisition of STAAR Surgical by Alcon

1. Broadwood Partners plans to oppose Alcon's acquisition of STAAR Surgical. 2. Broadwood holds 27.3% shares and is STAAR's largest long-term shareholder.

M&A
+0.35%Current Return
VS
-0.63%S&P 500
$27.3609/02 07:51 AM EDTEvent Start
$27.45509/03 02:20 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

Broadwood's opposition highlights potential discontent among major shareholders, which may lead to a decline in confidence. Historically, significant shareholder resistance has resulted in reduced stock prices, especially during M&A discussions.

How important is it?

Broadwood's stance as the largest shareholder directly affects investor sentiment and may influence future stock performance. As an involved party, their actions can sway market opinions and affect STAAR's stock value considerably.

Why Short Term?

Immediate investor reactions to acquisition opposition can lead to short-term volatility. Market sentiment tends to react quickly to news involving major shareholding movements.

Related Companies

ALCSTAA
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (together, “Broadwood”) currently intend to vote against the proposed acquisition of STAAR Surgical Company by Alcon Inc. Broadwood is STAAR's largest shareholder, owning 27.3% of STAAR's common shares outstanding. Broadwood has owned STAAR shares for over 30 years, has been the company's largest shareholder since 2007, and has long been one of STAAR's largest and most supportive stockholders, including by providing capital.

Related News